Concepts (126)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stroke | 15 | 2018 | 31 | 2.680 |
Why?
|
| Thrombectomy | 6 | 2018 | 10 | 1.480 |
Why?
|
| Cerebral Angiography | 4 | 2016 | 4 | 1.400 |
Why?
|
| Intracranial Aneurysm | 3 | 2016 | 6 | 1.320 |
Why?
|
| Brain Ischemia | 8 | 2018 | 14 | 1.160 |
Why?
|
| Intracranial Hemorrhages | 4 | 2017 | 6 | 1.110 |
Why?
|
| Humans | 27 | 2018 | 2210 | 1.040 |
Why?
|
| Arteriovenous Fistula | 2 | 2016 | 2 | 0.970 |
Why?
|
| Intracranial Arteriovenous Malformations | 2 | 2016 | 4 | 0.970 |
Why?
|
| Aneurysm, Ruptured | 2 | 2016 | 5 | 0.960 |
Why?
|
| Endovascular Procedures | 8 | 2018 | 12 | 0.950 |
Why?
|
| Embolization, Therapeutic | 3 | 2014 | 4 | 0.940 |
Why?
|
| Female | 14 | 2018 | 1137 | 0.780 |
Why?
|
| Arterial Occlusive Diseases | 3 | 2017 | 3 | 0.760 |
Why?
|
| Middle Aged | 12 | 2018 | 608 | 0.750 |
Why?
|
| Male | 14 | 2018 | 1214 | 0.710 |
Why?
|
| Aged | 11 | 2018 | 490 | 0.680 |
Why?
|
| Cerebrovascular Disorders | 3 | 2015 | 4 | 0.660 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2014 | 85 | 0.560 |
Why?
|
| Patient Transfer | 1 | 2017 | 4 | 0.540 |
Why?
|
| Adult | 7 | 2018 | 681 | 0.540 |
Why?
|
| Neurosurgery | 2 | 2015 | 2 | 0.490 |
Why?
|
| Periodicals as Topic | 2 | 2015 | 9 | 0.490 |
Why?
|
| Informed Consent | 1 | 2015 | 7 | 0.470 |
Why?
|
| Self-Help Groups | 1 | 2014 | 1 | 0.460 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2014 | 5 | 0.450 |
Why?
|
| Social Media | 1 | 2014 | 14 | 0.450 |
Why?
|
| Aged, 80 and over | 7 | 2018 | 235 | 0.450 |
Why?
|
| Retrospective Studies | 7 | 2018 | 200 | 0.440 |
Why?
|
| Vascular Access Devices | 1 | 2013 | 1 | 0.430 |
Why?
|
| Cerebral Arteries | 1 | 2013 | 2 | 0.430 |
Why?
|
| Checklist | 1 | 2011 | 3 | 0.370 |
Why?
|
| Intraoperative Complications | 1 | 2011 | 6 | 0.370 |
Why?
|
| Predictive Value of Tests | 3 | 2017 | 40 | 0.360 |
Why?
|
| Follow-Up Studies | 4 | 2018 | 133 | 0.290 |
Why?
|
| Stents | 3 | 2018 | 6 | 0.250 |
Why?
|
| Morbidity | 2 | 2016 | 3 | 0.240 |
Why?
|
| Adolescent | 3 | 2018 | 218 | 0.240 |
Why?
|
| False Positive Reactions | 2 | 2017 | 4 | 0.240 |
Why?
|
| Young Adult | 3 | 2018 | 209 | 0.240 |
Why?
|
| Practice Guidelines as Topic | 2 | 2015 | 17 | 0.230 |
Why?
|
| Magnetic Resonance Angiography | 2 | 2016 | 5 | 0.230 |
Why?
|
| Prognosis | 2 | 2016 | 38 | 0.230 |
Why?
|
| Thrombolytic Therapy | 3 | 2014 | 10 | 0.220 |
Why?
|
| Treatment Outcome | 5 | 2018 | 232 | 0.210 |
Why?
|
| Clinical Trials as Topic | 3 | 2015 | 22 | 0.170 |
Why?
|
| Tissue Plasminogen Activator | 3 | 2015 | 5 | 0.170 |
Why?
|
| Angiography, Digital Subtraction | 2 | 2016 | 3 | 0.150 |
Why?
|
| Fibrinolytic Agents | 3 | 2017 | 10 | 0.150 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2016 | 44 | 0.150 |
Why?
|
| Societies, Medical | 2 | 2015 | 9 | 0.150 |
Why?
|
| Embolectomy | 2 | 2015 | 2 | 0.150 |
Why?
|
| Evidence-Based Medicine | 2 | 2015 | 12 | 0.140 |
Why?
|
| Neurologic Examination | 1 | 2016 | 6 | 0.130 |
Why?
|
| Computed Tomography Angiography | 1 | 2016 | 1 | 0.130 |
Why?
|
| Rupture, Spontaneous | 1 | 2016 | 1 | 0.130 |
Why?
|
| Databases, Factual | 1 | 2016 | 12 | 0.120 |
Why?
|
| Subdural Effusion | 1 | 2015 | 1 | 0.120 |
Why?
|
| Hematoma, Subdural, Acute | 1 | 2015 | 1 | 0.120 |
Why?
|
| Research Report | 1 | 2015 | 1 | 0.120 |
Why?
|
| Neurosurgical Procedures | 1 | 2015 | 4 | 0.120 |
Why?
|
| Risk Factors | 1 | 2016 | 153 | 0.120 |
Why?
|
| Hospitalization | 1 | 2015 | 25 | 0.120 |
Why?
|
| Research Personnel | 1 | 2015 | 1 | 0.120 |
Why?
|
| Writing | 1 | 2015 | 4 | 0.120 |
Why?
|
| Patient Outcome Assessment | 1 | 2014 | 3 | 0.110 |
Why?
|
| Psychometrics | 1 | 2014 | 17 | 0.110 |
Why?
|
| Biomedical Research | 1 | 2014 | 9 | 0.110 |
Why?
|
| Posterior Cerebral Artery | 1 | 2014 | 1 | 0.110 |
Why?
|
| Aneurysm | 1 | 2014 | 2 | 0.110 |
Why?
|
| Surveys and Questionnaires | 1 | 2014 | 102 | 0.110 |
Why?
|
| Child | 1 | 2015 | 161 | 0.110 |
Why?
|
| False Negative Reactions | 1 | 2013 | 1 | 0.110 |
Why?
|
| Tertiary Care Centers | 1 | 2013 | 4 | 0.110 |
Why?
|
| Pilot Projects | 1 | 2013 | 29 | 0.110 |
Why?
|
| Chicago | 1 | 2013 | 65 | 0.100 |
Why?
|
| Cross-Sectional Studies | 1 | 2013 | 69 | 0.100 |
Why?
|
| Prospective Studies | 1 | 2013 | 137 | 0.100 |
Why?
|
| Angioplasty | 2 | 2010 | 2 | 0.090 |
Why?
|
| Radiography | 1 | 2011 | 61 | 0.090 |
Why?
|
| Injections, Intra-Arterial | 1 | 2011 | 3 | 0.090 |
Why?
|
| Transportation of Patients | 1 | 2011 | 2 | 0.090 |
Why?
|
| Assisted Circulation | 1 | 2010 | 1 | 0.080 |
Why?
|
| Hypothermia, Induced | 1 | 2010 | 2 | 0.080 |
Why?
|
| Angioplasty, Balloon | 1 | 2009 | 1 | 0.080 |
Why?
|
| Cholestasis, Extrahepatic | 1 | 2008 | 1 | 0.070 |
Why?
|
| Bile Ducts, Intrahepatic | 1 | 2008 | 1 | 0.070 |
Why?
|
| Human Growth Hormone | 1 | 2008 | 1 | 0.070 |
Why?
|
| Hepatocyte Nuclear Factor 6 | 1 | 2008 | 1 | 0.070 |
Why?
|
| Intracranial Thrombosis | 1 | 2008 | 1 | 0.070 |
Why?
|
| Recovery of Function | 1 | 2008 | 19 | 0.070 |
Why?
|
| Time Factors | 2 | 2011 | 159 | 0.040 |
Why?
|
| Single-Blind Method | 1 | 2018 | 11 | 0.040 |
Why?
|
| Bayes Theorem | 1 | 2017 | 3 | 0.040 |
Why?
|
| Cerebral Infarction | 1 | 2017 | 6 | 0.040 |
Why?
|
| Disability Evaluation | 1 | 2017 | 9 | 0.040 |
Why?
|
| Combined Modality Therapy | 1 | 2017 | 19 | 0.040 |
Why?
|
| Time-to-Treatment | 1 | 2017 | 5 | 0.030 |
Why?
|
| Animals | 2 | 2010 | 734 | 0.030 |
Why?
|
| Reperfusion | 1 | 2015 | 1 | 0.030 |
Why?
|
| Patient Selection | 1 | 2015 | 8 | 0.030 |
Why?
|
| Disease Management | 1 | 2015 | 10 | 0.030 |
Why?
|
| Multicenter Studies as Topic | 1 | 2014 | 6 | 0.030 |
Why?
|
| Forecasting | 1 | 2014 | 12 | 0.030 |
Why?
|
| Speech Disorders | 1 | 2014 | 1 | 0.030 |
Why?
|
| United States | 1 | 2015 | 174 | 0.030 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2014 | 5 | 0.030 |
Why?
|
| Registries | 1 | 2011 | 20 | 0.020 |
Why?
|
| Carotid Arteries | 1 | 2009 | 1 | 0.020 |
Why?
|
| Middle Cerebral Artery | 1 | 2009 | 1 | 0.020 |
Why?
|
| Acute Disease | 1 | 2009 | 21 | 0.020 |
Why?
|
| Cholesterol 7-alpha-Hydroxylase | 1 | 2008 | 1 | 0.020 |
Why?
|
| Liver Regeneration | 1 | 2008 | 1 | 0.020 |
Why?
|
| Organic Anion Transporters, Sodium-Dependent | 1 | 2008 | 1 | 0.020 |
Why?
|
| Cyclin D | 1 | 2008 | 1 | 0.020 |
Why?
|
| Ligation | 1 | 2008 | 3 | 0.020 |
Why?
|
| Symporters | 1 | 2008 | 2 | 0.020 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2008 | 2 | 0.020 |
Why?
|
| Cyclins | 1 | 2008 | 3 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2008 | 8 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2008 | 10 | 0.020 |
Why?
|
| Hepatocytes | 1 | 2008 | 2 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2008 | 19 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2008 | 33 | 0.020 |
Why?
|
| Mice | 1 | 2008 | 208 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2008 | 143 | 0.020 |
Why?
|